ClinConnect ClinConnect Logo
Search / Trial NCT06365346

Music Breathing Therapy for Children With Attention-deficit Hyperactivity Disorder and Their Caregivers

Launched by CHINESE UNIVERSITY OF HONG KONG · Apr 12, 2024

Trial Information

Current as of July 25, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is exploring a new approach called Music Breathing Therapy, designed for children aged 7 to 12 years who have Attention-Deficit Hyperactivity Disorder (ADHD) and their primary caregivers. The goal is to see if this therapy can help improve resilience, reduce emotional and behavioral issues in children, and lessen the stress and psychological distress that parents often experience. The trial will involve fun, interactive sessions using music and breathing techniques, and researchers want to know how well families accept and stick with the program.

To participate, children must have a documented ADHD diagnosis and be able to read and communicate in Chinese. Their parents, who must be 21 years or older and primary caregivers living with the child, also need to be able to read and communicate in Chinese. However, children with other serious health issues or those who have recently participated in music therapy are not eligible. Participants can expect to engage in enjoyable activities that may help both the child and the parent feel better emotionally and psychologically. This trial is currently recruiting participants, so it's a great opportunity for families looking for new ways to support their child's well-being.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Children
  • have a clinically documented diagnosis/suspected ADHD diagnosis according to DSM-5 criteria
  • aged 7 to 12 years (school age)
  • can read and communicate in Chinese
  • Parents
  • aged 21 years or above
  • are the primary caregivers and living together with the child
  • can read and communicate in Chinese
  • Exclusion Criteria:
  • Children
  • have other disabling diseases (physical disability, mental disability, autism) that might limit their full participation in the study.
  • have been engaged in any music intervention in the past 6 months
  • Parents
  • are caring for more than one child with a chronic or critical illness or caring for another family member with a chronic illness
  • has a diagnosed mental illness, cognitive impairment, or learning problem, and/or is taking regular psychotropic medications that might limit their full participation in the study
  • have been engaged in any music intervention in the past 6 months

About Chinese University Of Hong Kong

The Chinese University of Hong Kong (CUHK) is a prestigious research institution renowned for its commitment to advancing medical science and improving healthcare outcomes. As a clinical trial sponsor, CUHK leverages its extensive academic resources and interdisciplinary expertise to conduct innovative research that addresses critical health challenges. The university fosters collaboration among leading researchers, healthcare professionals, and industry partners, ensuring rigorous study design and implementation. CUHK is dedicated to upholding the highest ethical standards in clinical research, with a focus on translating findings into tangible benefits for patients and the broader community.

Locations

Hong Kong, , Hong Kong

Patients applied

0 patients applied

Trial Officials

Ankie Tan Cheung, PhD

Principal Investigator

Chinese University of Hong Kong

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported